# PRESS RELEASE 2008

- # [FDA Approves Ferring Pharmaceuticals’ Degarelix (Generic Name) for Treatment of Advanced Prostate Cancer](/content/fda-approves-ferring-pharmaceuticals-degarelix-generic-name-for-treatment-of-advanced-prostate-cancer/index.html)

Ferring Pharmaceuticals, USA today received approval from the U.S. Food and Drug Administration (FDA) for degarelix…

- # [Committee for Medicinal Products for Human Use (CHMP) recommends granting marketing authorisation for FIRMAGON® (degarelix) for treatment of prostate cancer](/content/committee-for-medicinal-products-for-human-use-chmp-recommends-granting-marketing-authorisation-for-firmagon-degarelix-for-treatment-of-prostate-cancer/index.html)

Ferring Pharmaceuticals received today notification that the Committee…

- # [Ferring and Conaris complete license agreement for new recombinant molecule in gastroenterology](/content/ferring-and-conaris-complete-license-agreement-for-new-recombinant-molecule-in-gastroenterology/index.html)

Ferring Pharmaceuticals and Conaris Research Institute AG today announced that they have completed…

- # [Ferring signs distribution agreement with BioGaia in Ireland and the Middle East](/content/ferring-signs-distribution-agreement-with-biogaia-in-ireland-and-the-middle-east/index.html)

BioGaia has extended its collaboration with the Swiss biopharmaceutical company Ferring Pharmaceuticals giving Ferring exclusive rights to sell BioGaia’s Probiotic Drops in Ireland and…

- # [Auxilium Pharmaceuticals, Inc. Announces Distribution and License Agreement for Testim® in Europe with Ferring Pharmaceuticals](/content/auxilium-pharmaceuticals-inc-announces-distribution-and-license-agreement-for-testim-in-europe-with-ferring-pharmaceuticals/index.html)

Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) and Ferring International S.A. today announced…

- # [Positive phase III data unveiled for new GnRH blocker degarelix](/content/positive-phase-3-data-unveiled-for-new-gnrh-blocker-degarelix/index.html)

Data from a Phase III study presented at the 23rd Annual European Association of Urology Congress demonstrated that the investigational GnRH blocker, degarelix…

- # [Ferring Pharmaceuticals submits new drug application for degarelix, a prostate cancer treatment](/content/ferring-pharmaceuticals-submits-new-drug-application-for-degarelix-a-prostate-cancer-treatment/index.html)

Ferring Pharmaceuticals announced today that it has submitted applications in Europe and the United States for…

- # [Launch of new, prestigious infertility and gynaecology research grant (FRIGGA) at “Update in Infertility 2008”](/content/launch-of-new-prestigious-infertility-and-gynaecology-research-grant-frigga-at-update-in-infertility-2008/index.html)

Ferring Pharmaceuticals today launches the first Ferring Research Infertility and Gynaecology GrAnt (FRIGGA) for fundamental fertility and gynaecology research…